This Week in Sleep Medicine: October 30, 2018
While You Were Sleeping: What Sleep Technologists Need to Know This Week
Your media watchdog for headlines and trends
relevant to sleep technology and patient education.
From the article: “Among withdrawal symptoms, the most commonly reported were nervousness/anxiety (76%), hostility (72%), sleep difficulty (68%), and depressed mood (59%). While physical symptoms were reported less frequently than behavioral and emotional symptoms, headaches, shakiness/tremors, and sweating were also prevalent.”
Takeaway: Granted, we're talking about heavy cannabis users, but it's worth considering how cannabinoids used to treat insomnia may be problematic should the patient wish to stop using them. Also, cannabis products may become habituated to, requiring higher doses over time to achieve sleep (or fend off sleep-onset insomnia). Today's light cannabis user may become tomorrow's heavy cannabis user.
HEALTH LITERACY WATCH
Mullica cop with sleep apnea will keep job and pension
PRESS OF ATLANTIC CITY
October 26, 2018
BIO: Tamara Sellman RPSGT, CCSH curates the sleep health information clearinghouse, SleepyHeadCENTRAL, where she follows sleep health news headlines daily. She is also an independent sleep health journalist, writes MS-related columns for two medical publishers, and contributes as a freelance writer to AAST’s magazine, A2Zzz. She can be reached at firstname.lastname@example.org.